Top Back to top

Evaluation of Outcomes following Allogeneic HCT in Pediatric Patients with High-Risk AML

Study number:
Short title:
Study status:
Deadline for data collection:
Study design:
Primary objective:
The primary end points are: overall survival
Secondary end points are: progression-free survival, non-relapse mortality, incidence of relapse
Key inclusion criteria:
Principal investigator:
Akshay Sharma
Principal investigator email:
EBMT Study coordinator:
Arnaud Dalissier
Study coordinator email: